Literature DB >> 19774651

Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.

Tim Serno1, John F Carpenter, Theodore W Randolph, Gerhard Winter.   

Abstract

In order to provide an alternative to nonionic surfactants as excipients for protein formulations, cyclodextrin-derivatives (CDs) were examined for their potential to inhibit agitation-induced aggregation of an IgG in aqueous solution. Loss of monomeric protein and protein aggregation were monitored throughout the agitation experiments by size exclusion chromatography. Hydroxypropyl-beta-cyclodextrin (HPbetaCD) completely suppressed IgG-aggregation at a remarkably low concentration (2.5 mM) and in contrast to other CDs it also did not negatively affect IgG-stability during storage in nonagitated solution. Further agitation experiments demonstrated the superiority of HPbetaCD to other common excipients in protein formulation, such as sugars and sugar alcohols or polysorbate 80 in low concentrations. Spectroscopic (fluorescence spectroscopy and Fourier transform infrared spectroscopy), thermodynamic (microcalorimetry), and physical investigations (surface tension measurements) were carried out to elucidate the mechanism of stabilization of the IgG. In contrast to other studies with HPbetaCD, protein stabilization could not be attributed to direct interaction between hydrophobic amino acids on the IgG and this excipient. Competition with the protein for the air-water interface appears to be the dominating mechanism of stabilization. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19774651     DOI: 10.1002/jps.21931

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  23 in total

1.  Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.

Authors:  Wei-Jie Fang; Wei Qi; John Kinzell; Steven Prestrelski; John F Carpenter
Journal:  Pharm Res       Date:  2012-07-06       Impact factor: 4.200

2.  The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.

Authors:  Shuang Chen; Hollis Lau; Yan Brodsky; Gerd R Kleemann; Ramil F Latypov
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

3.  Protein G, protein A and protein A-derived peptides inhibit the agitation induced aggregation of IgG.

Authors:  Jun Zhang; Elizabeth M Topp
Journal:  Mol Pharm       Date:  2012-02-09       Impact factor: 4.939

4.  Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

Authors:  Lili Wen; Xianxian Zheng; Xinyue Wang; Hairong Lan; Zongning Yin
Journal:  Pharm Res       Date:  2017-04-11       Impact factor: 4.200

Review 5.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

6.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

7.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

Review 8.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

9.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

10.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Authors:  Lu Liu; Wei Qi; Daniel K Schwartz; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2013-05-27       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.